Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.82 USD
-0.03 (-1.62%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.81 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 61 - 80 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Acquires HEXO''s Outstanding Convertible Notes, Provides Optionality
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: California To See Lots of Changes in 2022, Positive Developments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
2Q22 Sales Miss, New Cost Synergies to Offset Share and Pricing Pressure
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canada Challenges Persist, Adds Breckenridge Distillery to U.S. Footprint
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
German Coalition Party Leaders Reach Agreement to Legalize Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: MJBiz Takeaway Points Toward M&A in a Status Quo Environment
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: Federal Legislation Should Start Heating Up
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
1Q22 Flat Quarter, Muted Growth on Challenging Environment, PT to $11
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Weekly ReHash: Women in Cannabis Conference Recap, Brands Are The Key
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Conference Takeaways: Investing in Women Cannabis Pioneers
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Consumer- INVITE: Roth Virtual Investing in Women Cannabis Pioneers Event
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S